AdAlta Limited

ASX (AUD): AdAlta Limited (1AD)

Last Price

0.015

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Profile
1AD

Exchange: 

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO: 

Full Time Employees: 

IPO Date: 

CIK: 

ISIN: 

CUSIP: 

Beta: 

Last Dividend: 

Dcf Diff: 

Dcf: 

Description

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is headquartered in Bundoora, Australia.

Address

http://adalta.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment